Concepedia
Statistics
Publications
1
Citations
15
H-Index
Active since
2024
Affiliations
Lifespan(Current)
Xiaofeng Duan is an author at Lifespan specializing in squamous cell carcinoma, neoadjuvant therapy, and neoadjuvant therapy trials.
Publications per year
2024–2024
Neoadjuvant chemoimmunotherapy was associated with better short‐term survival of patients with locally advanced esophageal squamous cell carcinoma compared to neoadjuvant chemoradiotherapy
Xiaofeng Duan, Fangdong Zhao, Xiaobin Shang et al. · Cancer Medicine · 2024 · 15 citations · Full text
Medicine, Oncology, Surgery +17
1–1 of 1